DailyMed – CARDENE IV- nicardipine hydrochloride injection, solution – Inergency
[ad_1]
Container Label
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
For Intravenous Infusion Only.
Rx only
20 mg in 200 mL
(0.1 mg/mL)
GALAXY
Single-Dose Container
Discard unused portion
200 mL
Iso-osmotic
NDC 43066-026-10
Code 2G3447
Sterile, Nonpyrogenic
Each mL contains 0.1 mg NICARDIPINE HYDROCHLORIDE in 8.6 mg SODIUM
CHLORIDE, USP with 0.0192 mg CITRIC ACID ANHYDROUS, USP and 1.92
mg SORBITOL, NF. HYDROCHLORIC ACID and/or SODIUM HYDROXIDE may
have been added to adjust pH.
DOSAGE: See prescribing information.
CAUTIONS: Check for minute leaks by squeezing bag firmly. If leaks are
found, discard bag as sterility may be impaired. Do not use unless solution
is clear. Do not add supplemental medication. Must not be used in series
connections.
STORAGE: Store at controlled room temperature 20º to 25º C (68º to 77º F); refer
to USP Controlled Room Temperature. Protect from freezing. Avoid excessive
heat. PROTECT FROM LIGHT, STORE IN CARTON UNTIL READY TO USE.
United States. Patent Numbers 7612102 and 7659291
Cardene is a registered trademark of Chiesi USA, Inc. and is used under license.
Galaxy is a registered trademark of Baxter International Inc.
PREMIERProRx is a registered trademark of Premier Healthcare Alliance L.P.,
used under license
PREMIERProRx Logo
Manufactured and Marketed by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
To report suspected adverse reactions, contact Baxter Healthcare Corporation
at 1-866-888-2472
07-34-00-2156
*BAR CODE
POSITION ONLY
343066026103
Carton Label
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
NDC 43066-026-10
Code 2G3477
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
For Intravenous Infusion Only.
PREMIERProRx Logo
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
Rx only
20 mg in 200 mL
(0.1 mg/mL)
STORE IN CARTON
UNTIL READY TO USE
1 GALAXY Single Dose Container
Discard unused portion
20 mg in 200 mLl
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
(0.1 mg/mL)
UNVARNISHED AREA FOR
LOT AND EXP.
UCC/EAN 128 BAR CODE POSITION
1.75” W (excluding quiet zone)
0.5” H (excluding human readable)
(01) 00343066026103
20 mg in 200 mL
Iso-osmotic
Sterile, nonpyrogenic
Each mL contains 0.1 mg NICARDIPINE HYDROCHLORIDE in 8.6 mg SODIUM CHLORIDE, USP
with 0.0192 mg CITRIC ACID ANHYDROUS, USP and 1.92 mg SORBITOL, NF.HYDROCHLORIC ACID
and/or SODIUM HYDROXIDE may have been added to adjust pH.
DOSAGE: See prescribing information.
CAUTIONS: Check for minute leaks by squeezing bag firmly. If leaks are found, discard bag
as sterility may be impaired. Do not use unless solution is clear. Do not add
supplemental medication. Must not be used in series connections.
STORAGE: Store at controlled room temperature 20º to 25º C (68º to 77º F); refer to USP
Controlled Room Temperature. Protect from freezing. Avoid excessive heat.
PROTECT FROM LIGHT, STORE IN CARTON UNTIL READY TO USE.
United States. Patent Numbers 7612102 and 7659291
CARDENE is a registered trademark of Chiesi USA, Inc. and is used under license.
Galaxy is a registered trademark of Baxter International Inc.
PREMIERProRx® is a registered trademark of Premier Healthcare Alliance L.P., used under license.
Manufactured and Marketed by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
To report suspected adverse reactions, contact Baxter Healthcare Corporation
at 1-866-888-2472
07-01-00-0861
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
CARDENE I.V.
Nicardipine Hydrochloride
in 0.86% Sodium Chloride Injection
20 mg in 200 mL
Container Label
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
For Intravenous Infusion Only.
Rx only
40 mg in 200 mL
(0.2 mg/mL)
GALAXY
Single-Dose Container
Discard unused portion
200 mL
Iso-osmotic
NDC 43066-028-10
Code 2G3449
Sterile, Nonpyrogenic
Each mL contains 0.2 mg NICARDIPINE HYDROCHLORIDE in 8.3 mg SODIUM
CHLORIDE, USP with 0.0384 mg CITRIC ACID ANHYDROUS, USP and 3.84
mg SORBITOL, NF. HYDROCHLORIC ACID and/or SODIUM HYDROXIDE may
have been added to adjust pH.
DOSAGE: See prescribing information.
CAUTIONS: Check for minute leaks by squeezing bag firmly. If leaks are found,
discard bag as sterility may be impaired. Do not use unless solution is clear.
Do not add supplemental medication. Must not be used in series connections.
STORAGE: Store at controlled room temperature 20º to 25º C (68º to 77º F); refer
to USP Controlled Room Temperature. Protect from freezing. Avoid excessive
heat. PROTECT FROM LIGHT, STORE IN CARTON UNTIL READY TO USE.
United States. Patent Numbers 7612102 and 7659291
Cardene is a registered trademark of Chiesi USA, Inc. and is used under license.
Galaxy is a registered trademark of Baxter International Inc.
PREMIERProRx® is a registered trademark of Premier Healthcare Alliance L.P.,
used under license.
PREMIERProRx Logo
Manufactured and Marketed by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
To report suspected adverse reactions, contact Baxter Healthcare Corporation
at 1-866-888-2472
07-34-00-2157
*BAR CODE
POSITION ONLY
343066028107
Carton Label
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
DOUBLE CONCENTRATION:
CHECK INFUSION RATE
NDC 43066-028-10
Code 2G3449
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
For Intravenous Infusion Only.
DOUBLE CONCENTRATION:
CHECK INFUSION RATE
PREMIERProRx Logo
Rx only
40 mg in 200 mL
(0.2 mg/ml)
STORE IN CARTON
UNTIL READY TO USE
1 GALAXY Single Dose Container
Discard unused portion
40 mg in 200 mL
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
UNVARNISHED AREA FOR
LOT AND EXP.
GS1-128 BAR CODE POSITION
1.75” W (excluding quiet zone)
0.5” H (excluding human readable)
(01) 00343066028107
Iso-osmotic
Sterile, nonpyrogenic
Each mL contains 0.2 mg NICARDIPINE HYDROCHLORIDE in 8.3 mg SODIUM CHLORIDE, USP
with 0.0384 mg CITRIC ACID ANHYDROUS, USP and 3.84 mg SORBITOL, NF.HYDROCHLORIC
ACID and/or SODIUM HYDROXIDE may have been added to adjust pH.
DOSAGE: See prescribing information.
CAUTIONS: Check for minute leaks by squeezing bag firmly. If leaks are found, discard bag
as sterility may be impaired. Do not use unless solution is clear. Do not add
supplemental medication. Must not be used in series connections.
STORAGE: Store at controlled room temperature 20º to 25º C (68º to 77º F); refer to USP
Controlled Room Temperature. Protect from freezing. Avoid excessive heat.
PROTECT FROM LIGHT, STORE IN CARTON UNTIL READY TO USE.
United States. Patent Numbers 7612102 and 7659291
CARDENE is a registered trademark of Chiesi USA, Inc. and is used under license.
Galaxy is a registered trademark of Baxter International Inc.
PREMIERProRx® is a registered trademark of Premier Healthcare Alliance L.P., used under license.
Manufactured and Marketed by:
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
To report suspected adverse reactions, contact Baxter Healthcare Corporation
at 1-866-888-2472
07-01-00-0862
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
DOUBLE CONCENTRATION:
CHECK INFUSION RATE
CARDENE I.V.
Nicardipine Hydrochloride
in 0.83% Sodium Chloride Injection
40 mg in 200 mL
[ad_2]
